{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:52Z","timestamp":1793196592155,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004470","name":"Daewoong Pharmaceutical Co., Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004470","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00408-025-00815-5","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T03:17:33Z","timestamp":1745896653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and Safety of Fexuprazan Versus Esomeprazole for Gastroesophageal Reflux Disease-Related Chronic Cough: A Randomized, Double-Blind, Active-Controlled Exploratory Trial"],"prefix":"10.1007","volume":"203","author":[{"given":"Noeul","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Gyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jung","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Woo","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4630-9922","authenticated-orcid":false,"given":"Woo-Jung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"5","key":"815_CR1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1183\/09031936.00218714","volume":"45","author":"WJ Song","year":"2015","unstructured":"Song WJ, Chang YS, Faruqi S, Kim JY, Kang MG, Kim S, Jo EJ, Kim MH, Plevkova J, Park HW, Cho SH, Morice AH (2015) The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 45(5):1479\u20131481","journal-title":"Eur Respir J"},{"key":"815_CR2","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00157-2023","author":"L McGarvey","year":"2023","unstructured":"McGarvey L, Morice AH, Martin A, Li VW, Doane MJ, Urdaneta E, Schelfhout J, Ding H, Fonseca E (2023) Burden of chronic cough in the UK: results from the 2018 national health and wellness survey. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00157-2023","journal-title":"ERJ Open Res"},{"key":"815_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00806-2023","author":"L Guilleminault","year":"2024","unstructured":"Guilleminault L, Li VW, Fonseca E, Martin A, Schelfhout J, Ding H, Le Moine G (2024) Prevalence and burden of chronic cough in France. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00806-2023","journal-title":"ERJ Open Res"},{"issue":"4","key":"815_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/thorax.58.4.339","volume":"58","author":"SS Birring","year":"2003","unstructured":"Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58(4):339\u2013343","journal-title":"Thorax"},{"issue":"1","key":"815_CR5","doi-asserted-by":"publisher","first-page":"1901136","DOI":"10.1183\/13993003.01136-2019","volume":"55","author":"AH Morice","year":"2020","unstructured":"Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 55(1):1901136","journal-title":"Eur Respir J"},{"issue":"Suppl 6","key":"815_CR6","doi-asserted-by":"publisher","first-page":"s3","DOI":"10.1136\/thorax-2023-220592","volume":"78","author":"SM Parker","year":"2023","unstructured":"Parker SM, Smith JA, Birring SS et al (2023) British thoracic society clinical statement on chronic cough in adults. Thorax 78(Suppl 6):s3\u2013s19","journal-title":"Thorax"},{"issue":"3","key":"815_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jaip.2024.10.046","volume":"13","author":"WJ Song","year":"2025","unstructured":"Song WJ, Manian DV, Kim Y, Zhang M, Morice AH (2025) Cough reflex hypersensitivity as a key treatable trait. J Allergy Clin Immunol Pract 13(3):469\u2013478","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"815_CR8","first-page":"477","volume":"201","author":"EJ Jo","year":"2023","unstructured":"Jo EJ, Lee JH, Won HK et al (2023) Baseline cohort profile of the korean chronic cough registry: a multicenter, prospective. Observational Study Lung 201(5):477\u2013488","journal-title":"Observational Study Lung"},{"issue":"4","key":"815_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00408-022-00555-w","volume":"200","author":"J An","year":"2022","unstructured":"An J, Lee JH, Won HK et al (2022) Cough presentation and cough-related healthcare utilization in tertiary care: analysis of routinely collected academic institutional database. Lung 200(4):431\u2013439","journal-title":"Lung"},{"key":"815_CR10","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00232-2022","author":"JWK van den Berg","year":"2022","unstructured":"van den Berg JWK, Baxter CA, Edens MA, Patberg KW, van der Velden H, Weijerse A, Salomonsson S (2022) The demographics, clinical characteristics and quality of life of patients with chronic cough from the Isala Cough Clinic in the Netherlands. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00232-2022","journal-title":"ERJ Open Res"},{"issue":"6","key":"815_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00408-021-00496-w","volume":"199","author":"H Badri","year":"2021","unstructured":"Badri H, Satia I, Bansal V, Mangi MA, Tangaroonsanti A, DeVault KR, Lee AS, Houghton LA, Smith JA (2021) Heartburn as a marker of the success of acid suppression therapy in chronic cough. Lung 199(6):597\u2013602","journal-title":"Lung"},{"issue":"4","key":"815_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.alit.2019.04.011","volume":"68","author":"Y Kanemitsu","year":"2019","unstructured":"Kanemitsu Y, Kurokawa R, Takeda N et al (2019) Clinical impact of gastroesophageal reflux disease in patients with subacute\/chronic cough. Allergol Int 68(4):478\u2013485","journal-title":"Allergol Int"},{"issue":"1","key":"815_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0000000000001907","volume":"265","author":"F Sidhwa","year":"2017","unstructured":"Sidhwa F, Moore A, Alligood E, Fisichella PM (2017) Diagnosis and treatment of the extraesophageal manifestations of gastroesophageal reflux disease. Ann Surg 265(1):63\u201367","journal-title":"Ann Surg"},{"issue":"6","key":"815_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4168\/aair.2018.10.6.591","volume":"10","author":"DJ Song","year":"2018","unstructured":"Song DJ, Song WJ, Kwon JW et al (2018) KAAACI evidence-based clinical practice guidelines for chronic cough in adults and children in Korea. Allergy Asthma Immunol Res 10(6):591\u2013613","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"815_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.chest.2016.08.1458","volume":"150","author":"PJ Kahrilas","year":"2016","unstructured":"Kahrilas PJ, Altman KW, Chang AB, Field SK, Harding SM, Lane AP, Lim K, McGarvey L, Smith J, Irwin RS, Panel CEC (2016) Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report. Chest 150(6):1341\u20131360","journal-title":"Chest"},{"issue":"3","key":"815_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1378\/chest.12-1788","volume":"143","author":"PJ Kahrilas","year":"2013","unstructured":"Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M (2013) Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest 143(3):605\u2013612","journal-title":"Chest"},{"issue":"7","key":"815_CR17","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1440-1843.2011.02014.x","volume":"16","author":"S Faruqi","year":"2011","unstructured":"Faruqi S, Molyneux ID, Fathi H, Wright C, Thompson R, Morice AH (2011) Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study. Respirology 16(7):1150\u20131156","journal-title":"Respirology"},{"issue":"10","key":"815_CR18","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/j.1365-2036.2006.02911.x","volume":"23","author":"NT Gunaratnam","year":"2006","unstructured":"Gunaratnam NT, Jessup TP, Inadomi J, Lascewski DP (2006) Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Aliment Pharmacol Ther 23(10):1473\u20131477","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"815_CR19","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1007\/s10620-010-1209-2","volume":"55","author":"WD Chey","year":"2010","unstructured":"Chey WD, Mody RR, Izat E (2010) Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci 55(12):3415\u20133422","journal-title":"Dig Dis Sci"},{"issue":"6","key":"815_CR20","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1053\/j.gastro.2024.06.038","volume":"167","author":"A Patel","year":"2024","unstructured":"Patel A, Laine L, Moayyedi P, Wu J (2024) AGA clinical practice update on integrating potassium-competitive acid blockers into clinical practice: expert review. Gastroenterology 167(6):1228\u20131238","journal-title":"Gastroenterology"},{"issue":"1","key":"815_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/j.gastro.2022.09.041","volume":"164","author":"L Laine","year":"2023","unstructured":"Laine L, DeVault K, Katz P, Mitev S, Lowe J, Hunt B, Spechler S (2023) Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial. Gastroenterology 164(1):61\u201371","journal-title":"Gastroenterology"},{"issue":"44","key":"815_CR22","doi-asserted-by":"publisher","first-page":"6294","DOI":"10.3748\/wjg.v28.i44.6294","volume":"28","author":"KN Lee","year":"2022","unstructured":"Lee KN, Lee OY, Chun HJ et al (2022) Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis. World J Gastroenterol 28(44):6294\u20136309","journal-title":"World J Gastroenterol"},{"issue":"7","key":"815_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/apt.15185","volume":"49","author":"KJ Lee","year":"2019","unstructured":"Lee KJ, Son BK, Kim GH et al (2019) Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs esomeprazole in patients with erosive oesophagitis. Aliment Pharmacol Ther. 49(7):864\u2013872","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"815_CR24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/apt.13588","volume":"43","author":"T Kagami","year":"2016","unstructured":"Kagami T, Sahara S, Ichikawa H, Uotani T, Yamade M, Sugimoto M, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Furuta T (2016) Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype. Aliment Pharmacol Ther 43(10):1048\u20131059","journal-title":"Aliment Pharmacol Ther"},{"issue":"11\u201312","key":"815_CR25","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1111\/apt.16131","volume":"52","author":"JG Hwang","year":"2020","unstructured":"Hwang JG, Jeon I, Park SA, Lee A, Yu KS, Jang IJ, Lee S (2020) Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities. Aliment Pharmacol Ther 52(11\u201312):1648\u20131657","journal-title":"Aliment Pharmacol Ther"},{"key":"815_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-3-540-79842-2_16","volume":"187","author":"AA Raj","year":"2009","unstructured":"Raj AA, Pavord DI, Birring SS (2009) Clinical cough IV: what is the minimal important difference for the Leicester Cough Questionnaire? Handb Exp Pharmacol 187:311\u2013320","journal-title":"Handb Exp Pharmacol"},{"key":"815_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1477-7525-6-31","volume":"6","author":"M Shaw","year":"2008","unstructured":"Shaw M, Dent J, Beebe T, Junghard O, Wiklund I, Lind T, Johnsson F (2008) The reflux disease questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes 6:31","journal-title":"Health Qual Life Outcomes"},{"key":"815_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-230X-14-17","volume":"14","author":"E Rey","year":"2014","unstructured":"Rey E, Barcelo M, Zapardiel J, Sobreviela E, Munoz M, Diaz-Rubio M (2014) Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition? BMC Gastroenterol 14:17","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"815_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00408-019-00305-5","volume":"198","author":"R Eccles","year":"2020","unstructured":"Eccles R (2020) The Powerful placebo effect in cough: relevance to treatment and clinical trials. Lung 198(1):13\u201321","journal-title":"Lung"},{"key":"815_CR30","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00335-2024","author":"M Zhang","year":"2024","unstructured":"Zhang M, Zhang B, Morice AH (2024) Decoding the impact of the placebo response in clinical trials for chronic cough. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00335-2024","journal-title":"ERJ Open Res"},{"issue":"11","key":"815_CR31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1164\/rccm.202211-2128LE","volume":"207","author":"SS Birring","year":"2023","unstructured":"Birring SS, Dicpinigaitis PV, Smith JA et al (2023) Efficacy and safety of gefapixant for refractory or unexplained chronic cough over 52 weeks. Am J Respir Crit Care Med 207(11):1539\u20131542","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"815_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4168\/aair.2024.16.2.191","volume":"16","author":"S Zhong","year":"2024","unstructured":"Zhong S, Zhong M, Fang L et al (2024) Potassium-competitive acid blocker versus proton pump inhibitor: a pilot study on comparable efficacy in the treatment of gastroesophageal reflux-related cough. Allergy Asthma Immunol Res 16(2):191\u2013201","journal-title":"Allergy Asthma Immunol Res"},{"issue":"11","key":"815_CR33","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1007\/s00405-024-08877-6","volume":"281","author":"SI Kim","year":"2024","unstructured":"Kim SI, Lee YC, Cha W, Jung AR, Jang JY, Choi JS, Lee DK, Lee HH, Kwon MS, Lee YS, Eun YG (2024) Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial. Eur Arch Otorhinolaryngol 281(11):5873\u20135883","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"815_CR34","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00299-2024","author":"W Li","year":"2025","unstructured":"Li W, Sha B, Bai H, Zhang T, Wang S, Ambedkar Kumar Y, Zhu Y, Yu L, Xu X (2025) How to distinguish PPI-refractory from PPI-responsive patients in gastro-oesophageal reflux-induced chronic cough: post-reflux swallow induced peristaltic wave index and mean nocturnal baseline impedance provide new predictive factors. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00299-2024","journal-title":"ERJ Open Res"},{"issue":"6","key":"815_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/pharmaceutics13060813","volume":"13","author":"YS Jeong","year":"2021","unstructured":"Jeong YS, Kim MS, Lee N, Lee A, Chae YJ, Chung SJ, Lee KR (2021) Development of physiologically based pharmacokinetic model for orally administered fexuprazan in humans. Pharmaceutics. 13(6):813","journal-title":"Pharmaceutics."},{"issue":"2","key":"815_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1124\/jpet.117.244202","volume":"364","author":"N Takahashi","year":"2018","unstructured":"Takahashi N, Take Y (2018) Tegoprazan, a Novel potassium-competitive acid blocker to control gastric acid secretion and motility. J Pharmacol Exp Ther 364(2):275\u2013286","journal-title":"J Pharmacol Exp Ther"},{"key":"815_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/aoe-20-80","volume":"5","author":"KH Boulton","year":"2022","unstructured":"Boulton KH, Dettmar PW (2022) A narrative review of the prevalence of gastroesophageal reflux disease (GERD). Annals of Esophagus 5:7\u20137","journal-title":"Annals of Esophagus"},{"issue":"31","key":"815_CR38","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.3748\/wjg.v13.i31.4219","volume":"13","author":"T Watanabe","year":"2007","unstructured":"Watanabe T, Urita Y, Sugimoto M, Miki K (2007) Gastroesophageal reflux disease symptoms are more common in general practice in Japan. World J Gastroenterol 13(31):4219\u20134223","journal-title":"World J Gastroenterol"},{"key":"815_CR39","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00046-2024","author":"W Gu","year":"2024","unstructured":"Gu W, Chen W, Zhang T, Zhu Y, Li W, Shi W, Li N, Wang S, Xu X, Yu L (2024) Diagnostic value of the pepsin concentration in saliva and induced sputum for gastroesophageal reflux-induced chronic cough: a prospective clinical study. ERJ Open Res. https:\/\/doi.org\/10.1183\/23120541.00046-2024","journal-title":"ERJ Open Res"},{"issue":"4","key":"815_CR40","first-page":"318","volume":"42","author":"D Kanjanawasee","year":"2024","unstructured":"Kanjanawasee D, Poachanukoon O, Sriprasart T et al (2024) Chronic cough management: practical guidelines and PICO-based evidence for treatment. Asian Pac J Allergy Immunol 42(4):318\u2013332","journal-title":"Asian Pac J Allergy Immunol"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00815-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-025-00815-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-025-00815-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:42:58Z","timestamp":1766378578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-025-00815-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1007\/s00408-025-00815-5","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WJS declares receiving grants from Merck Sharp & Dohme Corp., and AstraZeneca; consulting fees from Merck, Bellus, AstraZeneca, Shionogi, and GSK; and lecture fees from Merck, AstraZeneca, GSK, Sanofi, and Novartis. MGK, SEL, SYK, EJJ, JHL, SHK, BJL, and SWJ received grant funding from Daewoong Pharmaceutical Co., Ltd. (Seoul, Korea) to their institution for the conduct of the submitted study. The grantor had no role in the study design, data collection, analysis, result interpretation, decision to publish, or manuscript preparation. The opinions expressed in this paper are entirely those of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the institutional review boards (IRBs) of each participating institution (IRB number: 2022-06-089).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from the parents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}],"article-number":"59"}}